About Sanara MedTech
Sanara MedTech is a company based in Fort Worth (United States) founded in 1982. The company has 141 employees as of December 31, 2024. Sanara MedTech has completed 2 acquisitions, including Precision Healing and Scendia Biologics. Sanara MedTech offers products and services including CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel. Sanara MedTech operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
- Headquarter Fort Worth, United States
- Employees 141 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sanara Medtech Inc.
-
Annual Revenue
$86.67 M (USD)33.36as on Dec 31, 2024
-
Net Profit
-$9.66 M (USD)-124.59as on Dec 31, 2024
-
EBITDA
-$3.73 M (USD)6.5as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
141
as on Dec 31, 2024
-
Investments & Acquisitions
Precision Healing
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sanara MedTech
Sanara MedTech is a publicly listed company on the NASDAQ with ticker symbol SMTI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sanara MedTech
Sanara MedTech offers a comprehensive portfolio of products and services, including CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel.
Aids in natural healing of surgical wounds using hydrolyzed collagen.
Reinforces soft tissue through porcine submucosa implantation.
Provides micronized matrix for managing surgical wounds effectively.
Serves as a barrier for various soft tissue applications.
Disrupts biofilms to aid in wound healing and microbe elimination.
People of Sanara MedTech
Unlock access to complete
Funding Insights of Sanara MedTech
Investments & Acquisitions by Sanara MedTech
Sanara MedTech has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Precision Healing and Scendia Biologics.
Investment portfolio details for Sanara MedTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bone minerals and traditional grafts are manufactured by Scendia Biologics.
|
Locked | Locked | 2016 | Locked | |
|
Therapeutic massage services are provided in Portland, United States.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Sanara MedTech
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sanara MedTech
Detailed financials for Sanara MedTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sanara Medtech Comparisons
Peer comparison for Sanara MedTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sanara MedTech
Sanara MedTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Gene therapy platform is developed for chronic disease treatments.
|
|
| Locked | Locked | Locked |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
Detailed competitors of Sanara MedTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sanara Medtech
Complete news archive for Sanara MedTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanara MedTech
Sanara MedTech was founded in 1982.
Sanara MedTech is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.
As of Dec 31, 2024, the latest employee count at Sanara MedTech is 141.
Annual revenue of Sanara MedTech is $86.67M as on Dec 31, 2024.
Developer of therapeutics for infectious disease. The platform has developed wound care products that include BIAKŌS for antimicrobial skin and wound cleaning and PULSAR II is the wound irrigation system. The platform also developed surgical products that include CellerateRX is surgical powder.
Sanara MedTech's top competitors include Vaxcyte, Serum Institute of India and Biological E.
Sanara MedTech offers CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel.
Yes, Sanara MedTech is publicly traded on NASDAQ under the ticker symbol SMTI.
Sanara MedTech has made 2 acquisitions, including Precision Healing, and Scendia Biologics.
The ticker symbol of Sanara MedTech is SMTI on NASDAQ.